Wenzel Spine received FDA 510(k) clearance to market the VariLift expandable interbody fusion system for stand-alone use, according to a company news release.
The VariLift-L is designed to be implanted as a single device using the transverse approach or bilaterally using the posterior approach. The VariLift-A is designed for bilateral implantation using the anterior approach. Both can be implanted with or without supplemental fixation.
The VeriLift system is available for fusion of the lumbar spine from L2 to S1 in skeletally mature patients who have had six months of non-operative treatment. The device can be used on one level or two contiguous levels for treatment of degenerative disc disease.
Read the Wenzel Spine release on the VariLift expandable interbody fusion system.
Read other coverage on spine devices:
- ArthroCare Receives FDA Clearance for Vertebral Augmentation Device
- Frost & Sullivan: Non-Fusion Spine Devices the Future for Manufacturers
- Aesculap Launches New Pedicle Screw System
The VariLift-L is designed to be implanted as a single device using the transverse approach or bilaterally using the posterior approach. The VariLift-A is designed for bilateral implantation using the anterior approach. Both can be implanted with or without supplemental fixation.
The VeriLift system is available for fusion of the lumbar spine from L2 to S1 in skeletally mature patients who have had six months of non-operative treatment. The device can be used on one level or two contiguous levels for treatment of degenerative disc disease.
Read the Wenzel Spine release on the VariLift expandable interbody fusion system.
Read other coverage on spine devices:
- ArthroCare Receives FDA Clearance for Vertebral Augmentation Device
- Frost & Sullivan: Non-Fusion Spine Devices the Future for Manufacturers
- Aesculap Launches New Pedicle Screw System